人福医药：前三季度净利润同比增长6.22%

Core Viewpoint - The company reported a decline in revenue for the third quarter of 2025, while net profit showed an increase, indicating mixed financial performance [1] Financial Performance - In Q3 2025, the company achieved operating revenue of 5.819 billion yuan, a year-on-year decrease of 7.36% [1] - The net profit attributable to shareholders for Q3 2025 was 534 million yuan, reflecting a year-on-year increase of 11.56% [1] - For the first three quarters of 2025, the company reported total operating revenue of 17.883 billion yuan, down 6.58% year-on-year [1] - The net profit attributable to shareholders for the first three quarters was 1.689 billion yuan, which is a year-on-year increase of 6.22% [1]